OncoTherapy Science Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 24.8%.

Top 18 shareholders own 14.89% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
4.61%	Yusuke Nakamura	12,511,000	JP¥400.4m	0%	no data
2.15%	Shuichi Nakatsuru	5,850,000	JP¥187.2m	0%	no data
1.45%	Yoichi Furukawa	3,943,000	JP¥126.2m	0%	no data
1.14%	Central Tanshi Co., Ltd., Asset Management Arm	3,099,600	JP¥99.2m	0%	0.28%
0.92%	Hirofumi Arakawa	2,487,400	JP¥79.6m	0%	no data
0.82%	Japan Securities Finance Co. Ltd., Asset Management Arm	2,225,100	JP¥71.2m	0%	0.01%
0.74%	Long Corridor Asset Management Limited	2,000,000	JP¥64.0m	-75.6%	0.42%
0.58%	Matsui Securities Co. Ltd., Asset Management Arm	1,570,300	JP¥50.2m	0%	0.2%
0.42%	Simplex Asset Management Co., Ltd.	1,136,100	JP¥36.4m	0%	0.02%
0.41%	SBI Holdings Inc., Asset Management Arm	1,114,211	JP¥35.7m	0%	0.01%
0.37%	Katsumi Suzuki	1,000,000	JP¥32.0m	0%	no data
0.36%	Kazuko Kitamura	978,000	JP¥31.3m	0%	no data
0.31%	Hiroshi Takeuchi	850,000	JP¥27.2m	0%	no data
0.3%	Takashi Maruta	828,000	JP¥26.5m	0%	no data
0.29%	Koji Toyooka	783,900	JP¥25.1m	0%	no data
0.018%	Yuka Yamane	50,000	JP¥1.6m	0%	no data
0.011%	Miyako Takagi	31,000	JP¥991.8k	0%	no data
0.00029%	Daiwa Asset Management Co., Ltd.	800	JP¥25.2k	0%	no data